Halberd and Mississippi State University to Commence Stage II Advanced TBI Nasal Spray Testing [Yahoo! Finance]
HALBERD CORP (HALB)
Company Research
Source: Yahoo! Finance
testing protocols at Mississippi State University (MSU) were approved by the Institutional Animal Care and Use Committee. Dr. Russell Carr, the Primary Investigator, initiated preparations for this extension of the successful Phase #1 pilot test program, completed last year with demonstrably compelling results . The advanced program will launch promptly. Numerous federal agencies expressed enthusiasm for the pursuit. Dr. Carr remarked, "The results obtained in the Phase #1 pilot were very promising and this project extension will strengthen those findings. We are excited to continue this line of research and look forward to getting started." William A. Hartman, Chairman, President, and CEO of Halberd Corporation, commented, "The results from the initial tests have demonstrated that we are on the right track. In this next Stage #2 Advanced phase of testing, we will focus on additional biomarkers and indicators of neural damage from head trauma to allow us to determine the extent of
Show less
Read more
Impact Snapshot
Event Time:
HALB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HALB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HALB alerts
High impacting HALBERD CORP news events
Weekly update
A roundup of the hottest topics
HALB
News
- Halberd's Patented Drug, LDN+, the Subject of a Limited Clinical Trial Under an Innovative Four-Company Cooperative Research and Development (CRADA) Contract [Yahoo! Finance]Yahoo! Finance
- Halberd's Patented Drug, LDN+, the Subject of a Limited Clinical Trial Under an Innovative Four-Company Cooperative Research and Development (CRADA) ContractAccesswire
- Halberd and Mississippi State University to Commence Stage II Advanced TBI Nasal Spray TestingAccesswire
- Halberd's Top Executives Join Forces with Athena GTX CEO Mark Darrah Unveiling 2024 Powerful Partnership Outlook on "The Street Reports Podcast" [Yahoo! Finance]Yahoo! Finance
- Halberd's Top Executives Join Forces with Athena GTX CEO Mark Darrah Unveiling 2024 Powerful Partnership Outlook on "The Street Reports Podcast"Accesswire